Shanshan Li

发表

Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking.

K. Yu, Jiayuh Lin, Hongbin Sun, 2017, Journal of medicinal chemistry.

Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy

Feiyan Liu, Ding-qiao Xu, L. Kong, 2017, Scientific Reports.

Inhibitors of protease-activated receptor 4 (PAR4): a review of recent patents (2013–2021)

Shanshan Li, Yi Kong, Xiong Zhu, 2022, Expert opinion on therapeutic patents.

Protease activated receptor 4 (PAR4) antagonists: Research progress on small molecules in the field of antiplatelet agents.

Shanshan Li, Yi Kong, Xiong Zhu, 2020, European journal of medicinal chemistry.

Development of a high speed counter-current chromatography system with Cu(II)-chiral ionic liquid complexes and hydroxypropyl-β-cyclodextrin as dual chiral selectors for enantioseparation of naringenin.

Lingyi Kong, Chao Han, Jianguang Luo, 2016, Journal of chromatography. A.

Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer.

Lingyi Kong, Sihui Long, Wenying Yu, 2021, Journal of medicinal chemistry.

Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein.

Lingyi Kong, Yanwei Yang, Ting Ma, 2016, European journal of medicinal chemistry.

Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors.

L. Kong, Wenying Yu, Jianpeng Guo, 2018, European journal of medicinal chemistry.

RETRACTED ARTICLE: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy

Chao Zhang, Wenying Yu, Jianpeng Guo, 2018, Cell Death & Disease.

A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy

L. Kong, Chao Zhang, Wenying Yu, 2018, Cell Death & Disease.

Antagonizing STAT3 activation with benzo[b]thiophene 1, 1-dioxide based small molecules.

Lingyi Kong, Yanwei Yang, Ting Ma, 2017, European journal of medicinal chemistry.